The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice

Insights Into the Role of Infection in Atherogenesis and in Plaque Rupture

(2009) Stephen E. Epstein et al.   CIRCULATION

Iron in arterial plaque: A modifiable risk factor for atherosclerosis

(2008) Jerome L. Sullivan   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in mice

(2008) J. M. Gitlin et al.   CARDIOVASCULAR RESEARCH

Genetic deficiency of NADPH oxidase does not diminish, but rather enhances, LPS-induced acute inflammatory responses in vivo

(2008) Wei-Jian Zhang et al.   FREE RADICAL BIOLOGY AND MEDICINE

Can Iron Chelators Influence the Progression of Atherosclerosis?

(2008) Joannes J.M. Marx et al.   HEMOGLOBIN

Antiinflammatory and Antiatherogenic Effects of the NF-κB Inhibitor Acetyl-11-Keto-β-Boswellic Acid in LPS-Challenged ApoE −/− Mice

(2007) Clarisse Cuaz-Pérolin et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY